Author:
Arora P,Cuevas B D,Russo A,Johnson G L,Trejo J
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Molecular Biology
Reference32 articles.
1. Arora P, Ricks TK, Trejo J . (2007). Protease-activated receptor signalling, endocytic sorting and dysregulation in cancer. J Cell Sci 120: 921–928.
2. Asakura M, Kitakaze M, Takashima S, Liao Y, Ishikura F, Yoshinaka T et al. (2002). Cardiac hypertrophy is inhibited by antagonisms of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy. Nat Med 8: 35–40.
3. Bergman S, Junker K, Henklein P, Hollenberg MD, Settmacher U, Kaufman R . (2006). PAR-type thrombin receptors in renal carcinoma cells: PAR1-mediated EGFR activation promotes cell migration. Oncol Rep 15: 889–893.
4. Boire A, Covic L, Agarwal A, Jacques S, Sherifi S, Kuliopulos A . (2005). PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells. Cell 120: 303–313.
5. Booden MA, Ekert L, Der CJ, Trejo J . (2004). Persistent signaling by dysregulated thrombin receptor trafficking promotes breast carcinoma cell invasion. Mol Cell Biol 24: 1990–1999.
Cited by
112 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献